4 Publications
2021
Signal Transduction and Molecular Regulation in Fatty Liver Disease.
Dong, Xiaocheng Charlie⋅Dong, X Charlie⋅Chowdhury, Kushan⋅Chowdhury, Kushan⋅Huang, Menghao⋅Huang, Menghao⋅Kim, Hyeong Geug and Kim, Hyeong-Geug
Antioxidants & redox signaling, vol. 35, (no. 9), pp. 689-717, September 20, 2021. | Journal Article
 
SIRT6 controls hepatic lipogenesis by suppressing LXR, ChREBP, and SREBP1.
Zhu, Chaoyu⋅Zhu, Chaoyu⋅Huang, Menghao⋅Huang, Menghao⋅Kim, Hyeong-Geug⋅Kim, Hyeong-Geug⋅Chowdhury, Kushan⋅Chowdhury, Kushan⋅Gao, Jing⋅Gao, Jing⋅Liu, Sheng⋅Liu, Sheng⋅Wan, Jun⋅Wan, Jun⋅Wei, Li⋅Wei, Li⋅Charlie Dong, X and Charlie Dong, X
Biochimica et biophysica acta. Molecular basis of disease, pp. 166249, August 20, 2021. | Journal Article
2020
Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping.
Liu, Zhipeng⋅Liu, Zhipeng⋅Zhang, Yang⋅Zhang, Yang⋅Graham, Sarah⋅Graham, Sarah⋅Wang, Xiaokun⋅Wang, Xiaokun⋅Cai, Defeng⋅Cai, Defeng⋅Huang, Menghao⋅Huang, Menghao⋅Pique-Regi, Roger⋅Pique-Regi, Roger⋅Dong, Xiaocheng Charlie⋅Dong, Xiaocheng Charlie⋅Chen, Y Eugene⋅Chen, Y Eugene⋅Willer, Cristen⋅Willer, Cristen⋅Liu, Wanqing and Liu, Wanqing
Journal of hepatology, vol. 73, (no. 2), pp. 263-276, August 2020. | Journal Article
2019
The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice.
Kim, Hyeong Geug⋅Kim, Hyeong Geug⋅Kim, Hyeong G⋅Huang, Menghao⋅Huang, Menghao⋅Huang, Menghao⋅Xin, Yue⋅Xin, Yue⋅Xin, Yue⋅Zhang, Yang⋅Zhang, Yang⋅Zhang, Yang⋅Zhang, Xinge⋅Zhang, Xinge⋅Zhang, Xinge⋅Wang, Gaihong⋅Wang, Gaihong⋅Wang, Gaihong⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Ahmadi, Ali Reza⋅Ahmadi, Ali R⋅Ahmadi, Ali Reza⋅Sun, Zhaoli⋅Sun, Zhaoli⋅Sun, Zhaoli⋅Liangpunsakul, Suthat⋅Liangpunsakul, Suthat⋅Liangpunsakul, Suthat⋅Xiong, Xiwen⋅Xiong, Xiwen⋅Xiong, Xiwen⋅Dong, Xiaocheng Charlie⋅Dong, Xiaocheng Charlie and Dong, Xiaocheng C
Journal of hepatology, vol. 71, (no. 5), pp. 960-969, November 2019. | Journal Article